CenTrak, the industry leader in real-time location technology, introduces the groundbreaking BLE Multi-Mode Platform, setting a new standard for Real-Time Location Systems (RTLS) in health care. Discover how this innovative solution enhances location data precision and streamlines operations for health care organizations.
CenTrak, a leading provider of real-time location technology, has introduced its advanced Bluetooth Low Energy (BLE) Multi-Mode Platform. This innovative Real-Time Location System (RTLS) solution is the first of its kind in the industry and has been designed to meet the unique needs of health care facilities. With its unparalleled location data capabilities and cost-effective deployment model, this cutting-edge platform provides health care providers with a reliable and efficient solution to their location tracking needs.
“CenTrak is proud to offer the industry’s first BLE Multi-Mode Platform, providing customers with simple, low-cost deployments for point-solution RTLS that can seamlessly scale to support enterprise use cases on a single platform,” noted Kevin Paroda, global segment manager for acute care in an exclusive quote to Infection Control Today. “Through this purposefully built advancement that effortlessly transitions between BLE and all CenTrak Clinical-Grade Locating (CGL) environments, health care organizations of all sizes are better able to provide scalable, high-quality visibility where it’s truly necessary and ensure peace of mind in tandem with a cost-effective price point.”
Building on the success of its ConnectRT cloud-based software platform, CenTrak's BLE Multi-Mode Platform features a hybrid architecture that seamlessly transitions between BLE and CenTrak Clinical-Grade Locating (CGL) environments. This interoperability allows customers to optimize their RTLS infrastructure with a mix of technologies across single buildings or entire hospital campuses, balancing affordability and precision based on departmental requirements.
“Our team proudly delivers yet another pivotal milestone in the company’s relentless pursuit of unprecedented innovation to integrate technology that supports health care professionals and further develops the modern connected hospital,” said Andrew Robinson, president and CEO at CenTrak. “With CenTrak, health care organizations worldwide can gain access to a versatile, scalable, and cost-effective solution for elevating staff safety and optimizing patient care.”
The platform's flagship product, the redesigned RTLS badge, provides health care providers with an accessible entry point to their RTLS journey. The badge boasts enhanced durability, extended battery life, easy over-the-air maintenance, and user-friendly features such as diagnostic LEDs and an audible buzzer. Each badge includes a dedicated emergency duress button, designed to prevent false alerts, along with 2 configurable buttons for custom workflows.
“The health care industry acknowledges the value of location data and the resulting [return on investment],” stated Crystal Ryan, chief commercial officer at CenTrak. “This recognition has prompted key decision-makers to invest in the transformative benefits that RTLS can deliver. Our groundbreaking BLE Multi-Mode Platform marks a substantial advancement in RTLS technology, solidifying our commitment to improving health care delivery with top-tier solutions and thoughtfully driving innovation.”
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
The Leapfrog Group and the Positive Effect on Hospital Hand Hygiene
November 21st 2024The Leapfrog Group enhances hospital safety by publicizing hand hygiene performance, improving patient safety outcomes, and significantly reducing health care-associated infections through transparent standards and monitoring initiatives.
Managing Multimorbidity and Polypharmacy in HIV: Insights From Michelle S. Cespedes, MD, MS
November 20th 2024Michelle S. Cespedes, MD, MS, discusses the challenges of managing multimorbidity and polypharmacy in HIV treatment, emphasizing patient education, evolving guidelines, and real-world insights from the REPRIEVE study.
Longhorn Vaccines and Diagnostics to Showcase Breakthrough Vaccine Data at IDWeek 2024
November 19th 2024Longhorn Vaccines and Diagnostics revealed promising data on universal influenza vaccine LHNVD-110 and AMR sepsis vaccine LHNVD-303 at IDWeek 2024, addressing critical global health challenges.